IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$284M
AUM Growth
+$26.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$12.6M
2
+$5.68M
3
+$4.84M
4
STML
Stemline Therapeutics, Inc.
STML
+$4.84M
5
EXEL icon
Exelixis
EXEL
+$4.74M

Top Sells

1
+$5.75M
2
+$5.23M
3
+$2.95M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$2.54M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2.36M

Sector Composition

1 Healthcare 91.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$20.7M 7.3%
65,008
-6,500
2
$19.8M 6.99%
190,022
+9,500
3
$15.4M 5.41%
40,830
4
$12.6M 4.44%
+14,067
5
$12.5M 4.4%
410,334
+156,000
6
$11.3M 3.99%
75,422
-13,300
7
$10.7M 3.76%
315,000
-75,000
8
$10M 3.54%
333,773
+93,000
9
$8.8M 3.1%
122,784
10
$8.66M 3.05%
72,441
-19,700
11
$8.48M 2.99%
51,496
+34,500
12
$8.32M 2.94%
341,468
13
$7.69M 2.71%
492,930
+310,000
14
$6.91M 2.44%
72,975
-16,000
15
$6.41M 2.26%
77,300
+42,300
16
$6.28M 2.21%
36,104
17
$6.11M 2.15%
477,500
+230,000
18
$6.1M 2.15%
68,384
19
$5.72M 2.02%
282,633
20
$5.17M 1.82%
76,000
+20,000
21
$4.84M 1.71%
+31,200
22
$4.67M 1.65%
36,800
-4,500
23
$4.54M 1.6%
253,500
+51,500
24
$3.97M 1.4%
46,487
25
$3.56M 1.26%
1,544
1
2 3